about
Is Wilms tumor a candidate neoplasia for treatment with WNT/β-catenin pathway modulators?--A report from the renal tumors biology-driven drug development workshopAGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and DStress-induced changes in the Schizosaccharomyces pombe proteome using two-dimensional difference gel electrophoresis, mass spectrometry and a novel integrated robotics platform.Mass spectrometry identification of circulating alpha-1-B glycoprotein, increased in aged female C57BL/6 mice.Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE).Sarcoidosis and tuberculosis cytokine profiles: indistinguishable in bronchoalveolar lavage but different in blood.Cell surface nucleolin on developing muscle is a potential ligand for the axonal receptor protein tyrosine phosphatase-sigmaUrinary proteome profiling using 2D-DIGE and LC-MS/MS.The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D.Cancer-specific transgene expression mediated by systemic injection of nanoparticles.Monitoring changes in nisin susceptibility of Listeria monocytogenes Scott A as an indicator of growth phase using FACS.Analysis of the urine proteome in patients with pancreatic ductal adenocarcinomaGlobal changes in gene expression observed at the transition from growth to stationary phase in Listeria monocytogenes ScottA batch cultureProteomic response of Schizosaccharomyces pombe to static and oscillating extremely low-frequency electromagnetic fieldsA parallel proteomic and metabolomic analysis of the hydrogen peroxide- and Sty1p-dependent stress response in Schizosaccharomyces pombe
P50
Q26829595-9568F4FE-3C4E-4CCC-89F3-B46375CE8CF3Q30532006-F8757D66-FBB6-4DED-BC2E-E2CE2263E9CCQ31155965-63D57BE1-58D9-4EDF-BC1B-5A04D0DD1F39Q33255983-9148F4E0-3AE1-412B-A3BD-369DF6BE10DAQ33514462-D8539115-1E9B-42C7-9931-B30B5605D0BCQ34344620-04E37517-55FE-4514-B5EB-0229B7A97573Q35785556-AB492E78-BE6A-4E6F-887C-87E55E244BB8Q39656206-2637B9AB-1569-4260-8FA9-6527801FD401Q40079528-0A183EFB-7EDE-48F7-99FC-2FC093ACBC14Q45883573-7FD9052E-9B93-460E-AA2A-7949D6BF3CFBQ46826847-0BCF2739-A8DB-42CA-94E2-D37AF5D89D9EQ57616809-14904F18-F2FD-4872-B354-A83D89F0F4ADQ75288676-C9F93DE2-BFF5-4F9B-B4E4-5FFA1ED1B9F9Q80082615-4AC780EB-50BA-405B-B458-9F3866328DF8Q82882736-1F823A4C-DDB4-447C-A50E-2028923E81C4
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mark E Weeks
@ast
Mark E Weeks
@en
Mark E Weeks
@es
Mark E Weeks
@nl
Mark E Weeks
@sl
type
label
Mark E Weeks
@ast
Mark E Weeks
@en
Mark E Weeks
@es
Mark E Weeks
@nl
Mark E Weeks
@sl
prefLabel
Mark E Weeks
@ast
Mark E Weeks
@en
Mark E Weeks
@es
Mark E Weeks
@nl
Mark E Weeks
@sl
P1053
C-2531-2011
P106
P21
P31
P3829
P496
0000-0002-6576-8809